What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Bacteria
- Antibiotics
The scientist’s investigation covers issues in Microbiology, Campylobacter, Campylobacter jejuni, Internal medicine and Immunology.
His Microbiology study often links to related topics such as Enterobacteriaceae.
His Campylobacter research includes elements of Erythromycin, 16S ribosomal RNA and Enteritis.
His study looks at the relationship between Campylobacter jejuni and fields such as Flagellin, as well as how they intersect with chemical problems.
His Internal medicine research is multidisciplinary, incorporating perspectives in Pseudomonas aeruginosa, Antibacterial agent and Intensive care medicine.
His Epidemiology study combines topics in areas such as Dysentery, Surgery and Typhoid fever.
His most cited work include:
- Practice Guidelines for the Management of Infectious Diarrhea (797 citations)
- Quinolone and Macrolide Resistance in Campylobacter jejuni and C. coli: Resistance Mechanisms and Trends in Human Isolates (581 citations)
- Campylobacter Species and Guillain-Barré Syndrome (462 citations)
What are the main themes of his work throughout his whole career to date?
Microbiology, Internal medicine, Campylobacter, Campylobacter jejuni and Immunology are his primary areas of study.
His Microbiology study incorporates themes from Escherichia coli and Bacteria.
Irving Nachamkin has researched Internal medicine in several fields, including Gastroenterology and Surgery.
His biological study deals with issues like Epidemiology, which deal with fields such as Antimicrobial.
His research is interdisciplinary, bridging the disciplines of Epitope and Campylobacter.
His research integrates issues of Molecular mimicry, Virology, Molecular biology, Typing and Flagellin in his study of Campylobacter jejuni.
He most often published in these fields:
- Microbiology (46.38%)
- Internal medicine (22.22%)
- Campylobacter (16.91%)
What were the highlights of his more recent work (between 2015-2020)?
- Internal medicine (22.22%)
- Microbiology (46.38%)
- Antibiotics (12.08%)
In recent papers he was focusing on the following fields of study:
Irving Nachamkin mainly focuses on Internal medicine, Microbiology, Antibiotics, Urinary system and Antibiotic resistance.
In Internal medicine, he works on issues like Gastroenterology, which are connected to Predictive value of tests and Fibrinogen.
His Microbiology research incorporates themes from Alternative medicine and Evidence-based practice.
When carried out as part of a general Antibiotics research project, his work on Ceftriaxone is frequently linked to work in In patient, therefore connecting diverse disciplines of study.
His research in Urinary system intersects with topics in Enterobacteriaceae, Cephalosporin Resistance and Cephalosporin.
His Immunology research is multidisciplinary, relying on both Isolation, Campylobacter jejuni and Campylobacter.
Between 2015 and 2020, his most popular works were:
- Effect of a Price Transparency Intervention in the Electronic Health Record on Clinician Ordering of Inpatient Laboratory Tests: The PRICE Randomized Clinical Trial (36 citations)
- Gut microbiome alteration in MORDOR I: a community-randomized trial of mass azithromycin distribution (29 citations)
- Multicenter Evaluation of Clinical Diagnostic Methods for Detection and Isolation of Campylobacter spp. from Stool (20 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Bacteria
- Antibiotics
Irving Nachamkin spends much of his time researching Internal medicine, Randomized controlled trial, Sepsis, Systemic inflammatory response syndrome and Procalcitonin.
The various areas that Irving Nachamkin examines in his Internal medicine study include Ambulatory care, Methicillin-resistant Staphylococcus aureus, Gastroenterology, Pharmacogenetics and Genotyping.
His study in Gastroenterology is interdisciplinary in nature, drawing from both Isolation, Predictive value of tests, Campylobacter jejuni and Immunology.
His Predictive value of tests study combines topics from a wide range of disciplines, such as Incidence, Multicenter study, Campylobacter, Tissue plasminogen activator and Cohort.
Irving Nachamkin interconnects Prospective cohort study and Fibrinogen in the investigation of issues within Sepsis.
The study incorporates disciplines such as Bacteremia, Surgery and Haptoglobin in addition to Fibrinogen.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
